Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

StockNews.com Begins Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)

Summary by defenseworld.net
StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report released on Wednesday. The firm issued a sell rating on the stock. Separately, Alliance Global Partners upped their price objective on shares of Tonix Pharmaceuticals from $6.00 to $11.00 and gave the company a “buy” rating in a research note on Monday, July 22nd. View Our Latest Report on TNXP Tonix Pharmaceuticals Stock Performance …
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Signature BankSignature Bank
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal